30 October - 3 November 2006

CODEX – Committee on Nutrition and Foods for Special Dietary Uses (28th Session) Chiang Mai, Thailand

SUMMARY AND CONCLUSIONS

The summary and conclusions of the 28th Session of the Codex Committee on Nutrition and Foods for Special Dietary Uses are as follows:

MATTERS FOR ADOPTION BY THE COMMISSION AT STEP 8

The Committee:

• Agreed to advanced the Draft Revised Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants: Section A: Draft Revised Standard for Infant Formula and Section B: Formulas for Special Medical Purposes Intended for Infants for final adoption by the 30th Session of the Commission (para 90, Appendix II).

MATTERS FOR ADOPTION BY THE COMMISSION AT STEP 5

The Committee:

• Agreed to advanced the Draft Revised Advisory List of Nutrient Compounds for Use in Foods for Special Dietary Uses Intended for the Use by Infants and Young Children for provisional adoption (para 130, Appendix V).

MATTERS FOR CONSIDERATION BY THE COMMISSION

The Committee:

• Agreed to start new work on the establishment and application of risk analysis principles by the Committee on Nutrition and Foods for Special Dietary Uses. The Project Document, prepared by Australia and presented in CX/NFSDU 06/289 would be forwarded to the 30th Session of the Commission for consideration of new work proposals (para. 143).

MATTERS OF INTEREST TO THE COMMISSION

The Committee:

• While considering the Implementation of the WHO/FAO Global Strategy on Diet, Physical Activity and Health, agreed to proceed with the consideration of the revision of the Nutrient Reference Values (NRVs) for vitamins and minerals and to ask the Committee on Food Labelling its advice concerning the revision and extension of the list of NRVs in the Guidelines for Nutrition Labelling to other nutrients associated with increased and decreased risk of non communicable diseases. The Committee agreed that if this reply was positive it would consider new work on the revision and extension of the list to relevant nutrients at its next session. The Committee concluded that there was no support to initiate work for claims for trans fatty acids and include restrictions on both saturated and trans fatty acids in the conditions for comparative claims. The Committee agreed to consider reviewing and re-establishing the Guidelines for the Use of Codex Committees on the Inclusion of Provisions on Nutritional Quality in Food Standards and Other Codex Texts at the next session of the Committee based on document which would provide more explanation on the development of such guidelines (see paras 144-156).

MATTERS REFERRED TO OTHER COMMITTEES

Codex Committee on Food Additives (CCFA)

• Following the established Procedures between Commodity Committees and General Committees, the CCNFSDU refers the Section on Food Additives of the Draft Revised Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants for endorsement and advice by the CCFA and JECFA (for details see paras 56-68 and 83-85 and Appendix III).

Codex Committee on Food Contaminants (CCFC)

• Following the established Procedures between Commodity Committees and General Committees, the CCNFSDU refers the Section on Food Contaminants of the Draft Revised Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants for endorsement and advice by the CCFC and JECFA (for details see paras 56-68 and 83-85 and Appendix II).

Codex Committee on Food Labelling (CCFL)

• Following the established Procedures between Commodity Committees and General Committees, the CCNFSDU refers the Section of Food Labelling of the Draft Revised Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants for endorsement by the CCFL (see paras 71-77 and 86-89 and Appendix II).

MATTERS FOR INFORMATION TO OTHER COMMITTEES

Codex Committee on Milk and Milk Products (CCMMP)

• The Committee recalled that the question of the nitrogen conversion factor had been substantially discussed at its earlier sessions, that the Committee on Milk and Milk Products had expressed the view that the conversion factor should be 6.38 as in the case of milk products and that the Commission had referred this question to the CCNFSDU for further consideration. The Committee agreed with the proposal of the working group to use a nitrogen conversion factor of 6.25 for infant formula “unless a scientific justification is provided for the use of a different conversion factor for a particular product”, and to indicate that a factor of 6.38 was used for other milk products, while the conversion factor in other soy products was 5.71. (for details see paras -29-33 and Appendix II).